FDA Announces Joint Meeting of Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss various topics related to anesthetic and analgesic drugs, as mandated by the Federal Food, Drug, and Cosmetic Act